Connection

Robert Gemmill to Carcinoma, Non-Small-Cell Lung

Back to Details
This is a "connection" page, showing publications Robert Gemmill has written about Carcinoma, Non-Small-Cell Lung.
Robert Gemmill
Connection Strength
1.808
Carcinoma, Non-Small-Cell Lung
  1. The neuropilin 2 isoform NRP2b uniquely supports TGF?-mediated progression in lung cancer. Sci Signal. 2017 01 17; 10(462).
    View in: PubMed
    Score: 0.433
  2. ZEB1-responsive genes in non-small cell lung cancer. Cancer Lett. 2011 Jan 01; 300(1):66-78.
    View in: PubMed
    Score: 0.281
  3. Induction of E-cadherin in lung cancer and interaction with growth suppression by histone deacetylase inhibition. J Thorac Oncol. 2009 Dec; 4(12):1455-65.
    View in: PubMed
    Score: 0.264
  4. MYC and EIF3H Coamplification significantly improve response and survival of non-small cell lung cancer patients (NSCLC) treated with gefitinib. J Thorac Oncol. 2009 Apr; 4(4):472-8.
    View in: PubMed
    Score: 0.252
  5. Neuropilin-2b facilitates resistance to tyrosine kinase inhibitors in non-small cell lung cancer. J Thorac Cardiovasc Surg. 2021 08; 162(2):463-473.
    View in: PubMed
    Score: 0.137
  6. ZEB1 Mediates Acquired Resistance to the Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer. PLoS One. 2016; 11(1):e0147344.
    View in: PubMed
    Score: 0.101
  7. Neuropilin-2 Is upregulated in lung cancer cells during TGF-?1-induced epithelial-mesenchymal transition. Cancer Res. 2013 Dec 01; 73(23):7111-21.
    View in: PubMed
    Score: 0.086
  8. Phase 1 clinical trial of the novel proteasome inhibitor marizomib with the histone deacetylase inhibitor vorinostat in patients with melanoma, pancreatic and lung cancer based on in vitro assessments of the combination. Invest New Drugs. 2012 Dec; 30(6):2303-17.
    View in: PubMed
    Score: 0.076
  9. Cyclooxygenase-2-dependent regulation of E-cadherin: prostaglandin E(2) induces transcriptional repressors ZEB1 and snail in non-small cell lung cancer. Cancer Res. 2006 May 15; 66(10):5338-45.
    View in: PubMed
    Score: 0.052
  10. High-throughput tissue microarray analysis used to evaluate biology and prognostic significance of the E-cadherin pathway in non-small-cell lung cancer. J Clin Oncol. 2002 May 15; 20(10):2417-28.
    View in: PubMed
    Score: 0.039
  11. Chromosomal duplication accompanies allelic loss in non-small cell lung carcinoma. Cancer Res. 1998 Oct 15; 58(20):4701-7.
    View in: PubMed
    Score: 0.031
  12. PTEN/MMAC1 mutations identified in small cell, but not in non-small cell lung cancers. Oncogene. 1998 Jul 30; 17(4):475-9.
    View in: PubMed
    Score: 0.030
  13. Restoring E-cadherin expression increases sensitivity to epidermal growth factor receptor inhibitors in lung cancer cell lines. Cancer Res. 2006 Jan 15; 66(2):944-50.
    View in: PubMed
    Score: 0.013
  14. Selective suppression of in vivo tumorigenicity by semaphorin SEMA3F in lung cancer cells. Neoplasia. 2005 May; 7(5):457-65.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.